Vaccine advisers eye autumn Covid boosters for over-65s
The Joint Committee on Vaccination and Immunisation (JCVI) on Thursday (May 19) said that an anticipated autumn Covid booster campaign would be aimed at...
PHARMA TRENDS: Covid vaccine makers shift focus to boosters
Covid-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot market after delivering as many doses as fast as...
Prince Charles praises pharmacy sector’s ‘dedication and professionalism’ during Covid-19 pandemic
Prince Charles has praised the "dedication and professionalism of pharmacy staff" at an event held in London to celebrate the work of community pharmacists...
Novavax files for authorisation of Covid-19 shot among adolescents in Britain
Novavax Inc said on Wednesday (May 4) it had filed an application with The Medicines and Healthcare products Regulatory Agency for the authorisation of...
‘Omicron as severe as previous Covid variants’
The Omicron variant of the SARS-CoV2 virus is intrinsically as severe as previous variants, unlike assumptions made in previous studies that it was more...
AstraZeneca sales beat forecasts on Covid jab demand
AstraZeneca on Friday (April 29) beat first-quarter sales and profit expectations, helped by higher than expected sales of its Covid-19 vaccine.
The vaccine recorded $1.15...
Prince Charles hosts a reception for 200 community pharmacists at St James’ Palace in May
His Royal Highness the Prince of Wales is to host a reception at St James’s Palace in early May to celebrate exemplary work of...
Second Global Covid-19 Summit slated for May 12
A second Global Covid-19 Summit will be held virtually next month for countries to discuss efforts to end the pandemic and prepare for future health...
ANALYSIS: Demand for Pfizer’s Covid pills lags around the world
Global demand for Pfizer's oral Covid-19 antiviral treatment Paxlovid has been unexpectedly low due to complicated eligibility requirements, reduced testing, and potential for drug...
Moderna’s Covid shot approved for 6-11 year-olds
Britain's medicines regulator on Thursday approved the use of Moderna 's Covid-19 vaccine in children between 6 and 11 years, as the country bolsters...
